These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


146 related items for PubMed ID: 9894583

  • 1. P300 subcomponents reflect different aspects of psychopathology in schizophrenia.
    Frodl-Bauch T, Gallinat J, Meisenzahl EM, Möller HJ, Hegerl U.
    Biol Psychiatry; 1999 Jan 01; 45(1):116-26. PubMed ID: 9894583
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. P300 subcomponent abnormalities in schizophrenia: I. Physiological evidence for gender and subtype specific differences in regional pathology.
    Turetsky BI, Colbath EA, Gur RE.
    Biol Psychiatry; 1998 Jan 15; 43(2):84-96. PubMed ID: 9474441
    [Abstract] [Full Text] [Related]

  • 5. Auditory P300 amplitude as a state marker for positive symptoms in schizophrenia: cross-sectional and retrospective longitudinal studies.
    Higashima M, Nagasawa T, Kawasaki Y, Oka T, Sakai N, Tsukada T, Koshino Y.
    Schizophr Res; 2003 Feb 01; 59(2-3):147-57. PubMed ID: 12414071
    [Abstract] [Full Text] [Related]

  • 6. Dipole source analysis of P300 component of the auditory evoked potential: a methodological advance?
    Hegerl U, Frodl-Bauch T.
    Psychiatry Res; 1997 May 16; 74(2):109-18. PubMed ID: 9204513
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Markers from event-related potential subcomponents and reaction time for information processing dysfunction in schizophrenia.
    Frodl T, Meisenzahl EM, Gallinat J, Hegerl U, Möller HJ.
    Eur Arch Psychiatry Clin Neurosci; 1998 May 16; 248(6):307-13. PubMed ID: 9928910
    [Abstract] [Full Text] [Related]

  • 10. Trait and state aspects of P300 amplitude reduction in schizophrenia: a retrospective longitudinal study.
    Mathalon DH, Ford JM, Pfefferbaum A.
    Biol Psychiatry; 2000 Mar 01; 47(5):434-49. PubMed ID: 10704955
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Reduced NGF serum levels and abnormal P300 event-related potential in first episode schizophrenia.
    Xiong P, Zeng Y, Zhu Z, Tan D, Xu F, Lu J, Wan J, Ma M.
    Schizophr Res; 2010 Jun 01; 119(1-3):34-9. PubMed ID: 20303241
    [Abstract] [Full Text] [Related]

  • 15. Auditory event-related potentials, auditory digit span, and clinical symptoms in chronic schizophrenic men on neuroleptic medication.
    Stefánsson SB, Jónsdóttir TJ.
    Biol Psychiatry; 1996 Jul 01; 40(1):19-27. PubMed ID: 8780851
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. State and trait markers of emotionally charged visual event-related potentials (P300) in drug-naïve schizophrenia.
    Mori K, Morita K, Shoji Y, Matsuoka T, Fujiki R, Uchimura N.
    Psychiatry Clin Neurosci; 2012 Jun 01; 66(4):261-9. PubMed ID: 22624730
    [Abstract] [Full Text] [Related]

  • 18. Auditory and visual P300 reflecting cognitive improvement in patients with schizophrenia with quetiapine: a pilot study.
    Park EJ, Han SI, Jeon YW.
    Prog Neuropsychopharmacol Biol Psychiatry; 2010 May 30; 34(4):674-80. PubMed ID: 20304022
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 8.